Compare · ISRG vs STE
ISRG vs STE
Side-by-side comparison of Intuitive Surgical Inc. (ISRG) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ISRG and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $162.13B, about 7.7x STE ($21.03B).
- ISRG has been more active in the news (15 items in the past 4 weeks vs 3 for STE).
- ISRG has more recent analyst coverage (25 ratings vs 16 for STE).
- Company
- Intuitive Surgical Inc.
- STERIS plc (Ireland)
- Price
- -
- -
- Market cap
- $162.13B
- $21.03B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2000
- News (4w)
- 15
- 3
- Recent ratings
- 25
- 16
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest ISRG
- SEC Form 4 filed by Director Guthart Gary S
- Director Reed Monica P converted options into 531 shares, increasing direct ownership by 23% to 2,876 units (SEC Form 4)
- Director Nachtsheim Jami K converted options into 531 shares, increasing direct ownership by 8% to 6,902 units (SEC Form 4)
- Director Leonard Keith R converted options into 531 shares, increasing direct ownership by 144% to 901 units (SEC Form 4)
- Director Ladd Amy L converted options into 531 shares, increasing direct ownership by 442% to 651 units (SEC Form 4)
- Director Kolli Sreelakshmi converted options into 531 shares, increasing direct ownership by 54% to 1,510 units (SEC Form 4)
- Director Johnson Amal M converted options into 531 shares, increasing direct ownership by 4% to 13,545 units (SEC Form 4)
- Director Chew Lewis converted options into 531 shares, increasing direct ownership by 68% to 1,314 units (SEC Form 4)
- Director Beery Joseph C converted options into 531 shares, increasing direct ownership by 17% to 3,641 units (SEC Form 4)
- Director Barratt Craig H converted options into 750 shares (SEC Form 4)
Latest STE
- STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
- Teleflex Announces Governance Updates
- SEC Form 8-K filed by STERIS plc (Ireland)
- Amendment: SEC Form SCHEDULE 13G/A filed by STERIS plc (Ireland)
- Director Feldmann Cynthia L exercised 3,098 units of Ordinary Shares at a strike of $152.32 and sold $734,877 worth of Ordinary Shares (3,098 units at $237.21) (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 10-Q filed by STERIS plc (Ireland)
- STERIS plc (Ireland) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- STERIS Announces Financial Results for Fiscal 2026 Third Quarter
- STERIS Announces Dividend of $0.63 per share